PTH and Vitamin D.
暂无分享,去创建一个
[1] J. Bilezikian,et al. Parathyroid hormone: anabolic and catabolic actions on the skeleton. , 2015, Current opinion in pharmacology.
[2] J. Welsh,et al. Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[3] John H. White,et al. Vitamin D and its receptor during late development. , 2015, Biochimica et biophysica acta.
[4] M. Rubin,et al. PTH(1-84) replacement therapy for the treatment of hypoparathyroidism , 2015, Expert review of endocrinology & metabolism.
[5] G. Eslick,et al. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. , 2014, Journal of hepatology.
[6] D. Gardner,et al. Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function , 2014, Hypertension.
[7] Wei Li,et al. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[8] Amita Sharma,et al. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. , 2014, Journal of the American Society of Nephrology : JASN.
[9] A. Arya,et al. Changes in parathyroid proteome in patients with primary hyperparathyroidism due to sporadic parathyroid adenomas , 2014, Clinical endocrinology.
[10] H. Morris,et al. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[11] L. Overbergh,et al. A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[12] D. Bikle,et al. LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[13] E. Orwoll,et al. Vitamin D and DBP: The free hormone hypothesis revisited , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[14] J. Adams,et al. Regulation of the extrarenal CYP27B1-hydroxylase , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[15] M. Uusitupa,et al. Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. , 2014, Molecular nutrition & food research.
[16] D. Canale,et al. Vitamin D Deficiency Aggravates Chronic Kidney Disease Progression after Ischemic Acute Kidney Injury , 2014, PloS one.
[17] Hilary F Luderer,et al. The vitamin D receptor is required for activation of cWnt and hedgehog signaling in keratinocytes. , 2014, Molecular endocrinology.
[18] C. Carlberg. The physiology of vitamin D—far more than calcium and bone , 2014, Front. Physiol..
[19] H. Toka,et al. The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease , 2014, Current opinion in nephrology and hypertension.
[20] M. Uusitupa,et al. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. , 2014, The Journal of nutritional biochemistry.
[21] J. Nowak,et al. The Role of Toll‐Like Receptors and Vitamin D in Diabetes Mellitus Type 1 – A Review , 2014, Scandinavian journal of immunology.
[22] J. Valdivielso,et al. Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals. , 2014, Atherosclerosis.
[23] Elizabeth L. Barry,et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. , 2014, The Journal of clinical endocrinology and metabolism.
[24] S. Majumdar,et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.
[25] R. Gibbs,et al. Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis. , 2014, The Journal of clinical endocrinology and metabolism.
[26] J. Reginster,et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. , 2014, The Journal of clinical endocrinology and metabolism.
[27] K. Ozono,et al. Elevated Fibroblast Growth Factor 23 Exerts Its Effects on Placenta and Regulates Vitamin D Metabolism in Pregnancy of Hyp Mice , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] K. H. Madsen,et al. Real-life use of vitamin D3-fortified bread and milk during a winter season: the effects of CYP2R1 and GC genes on 25-hydroxyvitamin D concentrations in Danish families, the VitmaD study , 2014, Genes & Nutrition.
[29] Toru Watanabe,et al. Association between Compound Heterozygous Mutations of SLC34A3 and Hypercalciuria , 2014, Hormone Research in Paediatrics.
[30] J. Burnett,et al. PTH: Potential role in management of heart failure. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[31] S. Bi,et al. Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis , 2014, Neuroscience Letters.
[32] K. Roemer,et al. Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling , 2014, Front. Physiol..
[33] F. Mach,et al. Potential pathophysiological role for the vitamin D deficiency in essential hypertension. , 2014, World journal of cardiology.
[34] P. Lips,et al. Diet, sun, and lifestyle as determinants of vitamin D status , 2014, Annals of the New York Academy of Sciences.
[35] J. Damoiseaux,et al. Vitamin D effects on B cell function in autoimmunity , 2014, Annals of the New York Academy of Sciences.
[36] Amanda B. Waddell,et al. The vitamin D receptor turns off chronically activated T cells , 2014, Annals of the New York Academy of Sciences.
[37] S. Heikkinen,et al. Patterns of Genome-Wide VDR Locations , 2014, PloS one.
[38] C. Carlberg. Genome-wide (over)view on the actions of vitamin D , 2014, Front. Physiol..
[39] C. Carlberg,et al. Characterization of Genomic Vitamin D Receptor Binding Sites through Chromatin Looping and Opening , 2014, PloS one.
[40] C. Wagner,et al. Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice. , 2014, American journal of physiology. Renal physiology.
[41] S. Garelli,et al. Diagnosis and classification of autoimmune parathyroid disease. , 2014, Autoimmunity reviews.
[42] D. Bikle. Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.
[43] Jin Wang,et al. In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland , 2014, Molecular and Cellular Endocrinology.
[44] Y. Li. Discovery of vitamin D hormone as a negative regulator of the renin-angiotensin system. , 2014, Clinical chemistry.
[45] P. Evenepoel,et al. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? , 2014, Seminars in nephrology.
[46] R. Kittles,et al. Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans , 2014, Cancer Causes & Control.
[47] J. Hoenderop,et al. Coordinated regulation of TRPV5-mediated Ca2+ transport in primary distal convolution cultures , 2014, Pflügers Archiv - European Journal of Physiology.
[48] S. Francis,et al. Vitamin D Deficiency and Exogenous Vitamin D Excess Similarly Increase Diffuse Atherosclerotic Calcification in Apolipoprotein E Knockout Mice , 2014, PloS one.
[49] J. Olson,et al. Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia , 2014, Proceedings of the National Academy of Sciences.
[50] M. Baum,et al. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. , 2014, American journal of physiology. Renal physiology.
[51] M. Frieri,et al. New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease. , 2014, Autoimmunity reviews.
[52] M. Bugliani,et al. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. , 2014, Endocrinology.
[53] S. Markova,et al. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. , 2014, The Journal of clinical endocrinology and metabolism.
[54] M. Vogiatzi,et al. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. , 2014, The Journal of clinical endocrinology and metabolism.
[55] P. Norman,et al. Vitamin D and cardiovascular disease. , 2014, Circulation research.
[56] R. Kumar,et al. A lifetime of hypercalcemia and hypercalciuria, finally explained. , 2014, The Journal of clinical endocrinology and metabolism.
[57] I. Reid,et al. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis , 2014, The Lancet.
[58] H. DeLuca. History of the discovery of vitamin D and its active metabolites. , 2014, BoneKEy reports.
[59] Dafang Zhang,et al. The Role of Recombinant PTH in Human Fracture Healing: A Systematic Review , 2014, Journal of orthopaedic trauma.
[60] Glenville Jones,et al. Cytochrome P450-mediated metabolism of vitamin D , 2014, Journal of Lipid Research.
[61] A. Quyyumi,et al. Vitamin D and cardiovascular disease: is the evidence solid? , 2013, European heart journal.
[62] K. Huse,et al. Mutation in CYP27A1 identified in family with coronary artery disease. , 2013, European journal of medical genetics.
[63] D. Santoro,et al. New Insights on the Role of Vitamin D in the Progression of Renal Damage , 2013, Kidney and Blood Pressure Research.
[64] A. Passaniti,et al. Vitamin D3 insufficiency and colorectal cancer. , 2013, Critical reviews in oncology/hematology.
[65] J. DiNicolantonio,et al. Vitamin D and cardiovascular health. , 2013, Circulation.
[66] D. Bogdanos,et al. Vitamin D in autoimmune liver disease. , 2013, Clinics and research in hepatology and gastroenterology.
[67] G. F. Persinoti,et al. Transcriptional profiling of Neurospora crassa Δmak-2 reveals that mitogen-activated protein kinase MAK-2 participates in the phosphate signaling pathway. , 2013, Fungal genetics and biology : FG & B.
[68] A. Turner,et al. Vitamin D activities and metabolic bone disease. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[69] C. Wagner,et al. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. , 2013, The Journal of clinical endocrinology and metabolism.
[70] B. Kestenbaum,et al. Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study. , 2013, The Journal of clinical endocrinology and metabolism.
[71] P. Glendenning,et al. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. , 2013, Bone.
[72] H. DeLuca,et al. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.
[73] Y. Li. Vitamin D receptor signaling in renal and cardiovascular protection. , 2013, Seminars in nephrology.
[74] E. Bongers,et al. Early development of hyperparathyroidism due to loss of PTH transcriptional repression in patients with HNF1β mutations? , 2013, The Journal of clinical endocrinology and metabolism.
[75] M. D. de Borst,et al. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. , 2013, Journal of the American Society of Nephrology : JASN.
[76] A. Arya,et al. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas. , 2013, The Journal of clinical endocrinology and metabolism.
[77] Glenville Jones. Extrarenal vitamin D activation and interactions between vitamin D₂, vitamin D₃, and vitamin D analogs. , 2013, Annual review of nutrition.
[78] C. Mathieu,et al. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: A comparison dose-titration study , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[79] D. Gardner,et al. Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[80] D. Eizirik,et al. Unraveling the effects of 1,25(OH)2D3 on global gene expression in pancreatic islets , 2013, The Journal of Steroid Biochemistry and Molecular Biology.
[81] N. Pellegata,et al. Multiple endocrine neoplasia syndromes associated with mutation of p27 , 2013, Journal of Endocrinological Investigation.
[82] K. White,et al. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. , 2013, Bone.
[83] F. Inserra,et al. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. , 2013, American journal of physiology. Cell physiology.
[84] E. Nemeth. Allosteric modulators of the extracellular calcium receptor. , 2013, Drug discovery today. Technologies.
[85] T. Bellido,et al. Effects of PTH on osteocyte function. , 2013, Bone.
[86] R. Thadhani,et al. The effect of vitamin D status on risk factors for cardiovascular disease , 2013, Nature Reviews Nephrology.
[87] D. Agrawal,et al. 1,25-dihydroxyvitamin D in the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma , 2013, Expert review of clinical immunology.
[88] M. Black,et al. Vitamin D Deficiency in Early Life and the Potential Programming of Cardiovascular Disease in Adulthood , 2013, Journal of Cardiovascular Translational Research.
[89] P. Esbrit,et al. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies. , 2013, Biochemical pharmacology.
[90] C. Wagner,et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. , 2013, Endocrinology.
[91] Jianping Xie,et al. Autophagy during Mycobacterium tuberculosis infection and implications for future tuberculosis medications. , 2013, Cellular signalling.
[92] K. Pang,et al. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. , 2013, American journal of physiology. Endocrinology and metabolism.
[93] Z. Massy,et al. Vitamin D therapy : an update. Vitamin D metabolites and/or analogs : which D for which Patient? , 2013 .
[94] S. Khundmiri,et al. Parathyroid hormone (PTH) decreases sodium-phosphate cotransporter type IIa (NpT2a) mRNA stability. , 2013, American journal of physiology. Renal physiology.
[95] A. Feuchtinger,et al. Characterization of MENX‐associated pituitary tumours , 2013, Neuropathology and applied neurobiology.
[96] J. Wetzels,et al. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease. , 2013, The American journal of pathology.
[97] H. Jüppner,et al. Activation of a non-cAMP/PKA signaling pathway downstream of the PTH/PTHrP receptor is essential for a sustained hypophosphatemic response to PTH infusion in male mice. , 2013, Endocrinology.
[98] L. Beveridge,et al. Vitamin D and the cardiovascular system , 2013, Osteoporosis International.
[99] R. Thadhani,et al. Does vitamin D modulate blood pressure? , 2013, Current opinion in nephrology and hypertension.
[100] L. Quarles,et al. A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. , 2013, Seminars in nephrology.
[101] Y. Keynan,et al. The Role of Polymorphisms in Host Immune Genes in Determining the Severity of Respiratory Illness Caused by Pandemic H1N1 Influenza , 2013, Public Health Genomics.
[102] C. Mathieu,et al. Effects of vitamin D on antigen‐specific and non‐antigen‐specific immune modulation: relevance for type 1 diabetes , 2013, Pediatric diabetes.
[103] B. Stack,et al. Characterization of hyperparathyroidism in youth and adolescents: a literature review. , 2013, International journal of pediatric otorhinolaryngology.
[104] J. Romijn,et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. , 2013, European journal of endocrinology.
[105] P. Leung,et al. Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin–angiotensin system in mice , 2013, Diabetologia.
[106] T. Ruzicka,et al. Vitamin D, the Cutaneous Barrier, Antimicrobial Peptides and Allergies: Is There a Link? , 2013, Allergy, asthma & immunology research.
[107] T. Spector,et al. Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts , 2013, PLoS medicine.
[108] Z. Dastani,et al. Genetic Regulation of Vitamin D Levels , 2013, Calcified Tissue International.
[109] M. Gershwin,et al. The Implication of Vitamin D and Autoimmunity: a Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.
[110] S. Weng,et al. Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice , 2013, PloS one.
[111] M. Brookhart,et al. Trends and Variations in Intravenous Vitamin D Use among Hemodialysis Patients in the United States , 2013, Renal failure.
[112] L. Mccauley,et al. Parathyroid Hormone Applications in the Craniofacial Skeleton , 2013, Journal of dental research.
[113] Duane D. Miller,et al. Novel vitamin D photoproducts and their precursors in the skin , 2013, Dermato-endocrinology.
[114] J. Bacchetta,et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐dihydroxyvitamin D in human monocytes , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[115] M. J. Mahon,et al. Fluorescent ligand-directed co-localization of the parathyroid hormone 1 receptor with the brush-border scaffold complex of the proximal tubule reveals hormone-dependent changes in ezrin immunoreactivity consistent with inactivation. , 2012, Biochimica et biophysica acta.
[116] N. Bhattacharyya,et al. Fibroblast growth factor 23: state of the field and future directions , 2012, Trends in Endocrinology & Metabolism.
[117] D. Deb,et al. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[118] P. Jurutka,et al. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[119] Xiuli Zhang,et al. Protective role of the vitamin D receptor. , 2012, Cellular immunology.
[120] L. Groome,et al. Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. , 2012, American journal of physiology. Endocrinology and metabolism.
[121] M. Makishima,et al. Vitamin D receptor activation induces peptide YY transcription in pancreatic islets. , 2012, Endocrinology.
[122] Alex J. Brown,et al. The vitamin D analog ED-71 is a potent regulator of intestinal phosphate absorption and NaPi-IIb. , 2012, Endocrinology.
[123] B. Lanske,et al. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway , 2012, Bone.
[124] M. Pelizzo,et al. Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism is Restored After Parathyroidectomy , 2012, Circulation.
[125] F. Arnold,et al. Review of metabolic, immunologic, and virologic consequences of suboptimal vitamin D levels in HIV infection. , 2012, AIDS patient care and STDs.
[126] M. Demay. Physiological Insights from the Vitamin D Receptor Knockout Mouse , 2012, Calcified Tissue International.
[127] Enrico Gratton,et al. NHE3 Regulatory Factor 1 (NHERF1) Modulates Intestinal Sodium-dependent Phosphate Transporter (NaPi-2b) Expression in Apical Microvilli* , 2012, The Journal of Biological Chemistry.
[128] R. Chun. New perspectives on the vitamin D binding protein , 2012, Cell biochemistry and function.
[129] T. Gardella,et al. Non-canonical signaling of the PTH receptor. , 2012, Trends in pharmacological sciences.
[130] E. Weinman,et al. NHERF-1 and the regulation of renal phosphate reabsoption: a tale of three hormones. , 2012, American journal of physiology. Renal physiology.
[131] J. Reichrath. Unravelling of hidden secrets: The role of vitamin D in skin aging , 2012, Dermato-endocrinology.
[132] D. Giorgio,et al. Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results , 2012, International journal of endocrinology.
[133] Mairead Kiely,et al. An updated systematic review and meta-analysis of the efficacy of vitamin D food fortification. , 2012, The Journal of nutrition.
[134] E. Taylor,et al. Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey , 2012, Osteoporosis International.
[135] L. Quarles,et al. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. , 2012, Experimental cell research.
[136] E. Weinman,et al. PTH-mediated inhibition of the renal transport of phosphate. , 2012, Experimental cell research.
[137] Amita Sharma,et al. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred. , 2012, Bone.
[138] R. Koren,et al. The inflammatory response of keratinocytes and its modulation by vitamin D: The role of MAPK signaling pathways , 2012, Journal of cellular physiology.
[139] L. Rejnmark,et al. PTH replacement therapy of hypoparathyroidism , 2012, Osteoporosis International.
[140] K. Miyamoto,et al. Clinical consequences of mutations in sodium phosphate cotransporters. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[141] B. Grandchamp,et al. A New Human NHERF1 Mutation Decreases Renal Phosphate Transporter NPT2a Expression by a PTH-Independent Mechanism , 2012, PloS one.
[142] W. März,et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. , 2012, Cardiovascular research.
[143] M. Hewison. An update on vitamin D and human immunity , 2012, Clinical endocrinology.
[144] Ryan E. Forster,et al. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis , 2012, Reviews in Endocrine and Metabolic Disorders.
[145] J. Chen,et al. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? , 2012, Molecular aspects of medicine.
[146] O. FitzGerald,et al. Vitamin D and its emerging role in immunopathology , 2012, Clinical Rheumatology.
[147] H. DeLuca,et al. Identification of the vitamin D receptor in various cells of the mouse kidney , 2012, Kidney international.
[148] L. Quarles,et al. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism , 2012, Nature Reviews Endocrinology.
[149] D. Ward,et al. New concepts in calcium‐sensing receptor pharmacology and signalling , 2012, British journal of pharmacology.
[150] C. Mathieu,et al. Vitamin D and diabetes: Its importance for beta cell and immune function , 2011, Molecular and Cellular Endocrinology.
[151] P. Malloy,et al. The role of vitamin D receptor mutations in the development of alopecia , 2011, Molecular and Cellular Endocrinology.
[152] L. Rejnmark,et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[153] Tim C. Lei,et al. Differential modulation of the molecular dynamics of the type IIa and IIc sodium phosphate cotransporters by parathyroid hormone. , 2011, American journal of physiology. Cell physiology.
[154] C. Mathieu,et al. Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. , 2011, Endocrinology.
[155] B. Lanske,et al. PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. , 2011, Endocrinology.
[156] H. Koepsell,et al. Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters. , 2011, Kidney international.
[157] D. Baldisseri,et al. Production of 22-Hydroxy Metabolites of Vitamin D3 by Cytochrome P450scc (CYP11A1) and Analysis of Their Biological Activities on Skin Cells , 2011, Drug Metabolism and Disposition.
[158] K. Miyamoto,et al. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. , 2011, Journal of pharmaceutical sciences.
[159] P. Elias,et al. Regulation of Cathelicidin Antimicrobial Peptide Expression by an Endoplasmic Reticulum (ER) Stress Signaling, Vitamin D Receptor-independent Pathway* , 2011, The Journal of Biological Chemistry.
[160] H. Henry. Regulation of vitamin D metabolism. , 2011, Best practice & research. Clinical endocrinology & metabolism.
[161] J. Aloia. The 2011 Report on Dietary Reference Intake for Vitamin D: Where Do We Go From Here? , 2011 .
[162] E. Hyppönen,et al. Determinants of vitamin D status: focus on genetic variations. , 2011, Current opinion in nephrology and hypertension.
[163] J. Welsh,et al. Over-expression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor null mice , 2011, The Journal of investigative dermatology.
[164] M. Hosojima,et al. Role of Megalin and Cubilin in the Metabolism of Vitamin D3 , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[165] G. Lärfars,et al. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. , 2011, The Journal of clinical endocrinology and metabolism.
[166] G. W. Vuister,et al. Molecular Mechanisms of Calmodulin Action on TRPV5 and Modulation by Parathyroid Hormone , 2011, Molecular and Cellular Biology.
[167] O. Tørring,et al. Emerging anabolic treatments in osteoporosis. , 2011, Current drug safety.
[168] P. Leung,et al. A novel role for vitamin D: modulation of expression and function of the local renin–angiotensin system in mouse pancreatic islets , 2011, Diabetologia.
[169] H. Dressman,et al. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor. , 2011, Molecular endocrinology.
[170] J. Svensson,et al. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism , 2011, Scandinavian journal of clinical and laboratory investigation.
[171] E. Weinman,et al. The regulation of renal phosphate transport. , 2011, Advances in chronic kidney disease.
[172] M. Levi,et al. Intestinal phosphate transport. , 2011, Advances in chronic kidney disease.
[173] Duane D. Miller,et al. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. , 2011, American journal of physiology. Cell physiology.
[174] A. Félix,et al. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses , 2011, Endocrine pathology.
[175] H. Jüppner. Phosphate and FGF-23 , 2011, Kidney international. Supplement.
[176] R. Kumar,et al. The regulation of parathyroid hormone secretion and synthesis. , 2011, Journal of the American Society of Nephrology : JASN.
[177] J. Krebs,et al. WSTF does it all: a multifunctional protein in transcription, repair, and replication. , 2011, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[178] M. Cantorna. Why do T cells express the vitamin D receptor? , 2011, Annals of the New York Academy of Sciences.
[179] Duane D. Miller,et al. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity , 2010, Steroids.
[180] A. Arnold,et al. Tissue‐specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[181] T. Shimada,et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. , 2010, Kidney international.
[182] A. Vaidya,et al. Vitamin D and Hypertension: Current Evidence and Future Directions , 2010, Hypertension.
[183] D. Bikle,et al. Disruption of the hedgehog signaling pathway contributes to the hair follicle cycling deficiency in Vdr knockout mice , 2010, Journal of cellular physiology.
[184] R. Khalil,et al. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. , 2010, Cardiovascular & hematological agents in medicinal chemistry.
[185] K. Jonsson,et al. The phosphate regulating hormone fibroblast growth factor‐23 , 2010, Acta physiologica.
[186] B. Kobilka,et al. Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. , 2010, Physiology.
[187] Nicholette D. Palmer,et al. Genome-wide association study of vitamin D concentrations in Hispanic Americans: The IRAS Family Study , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[188] A. Falchetti. 6. MEN syndromes , 2010 .
[189] O. Gutiérrez. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[190] R. Recker,et al. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects , 2010, Human Genetics.
[191] Wei Li,et al. Purified Mouse CYP27B1 Can Hydroxylate 20,23-Dihydroxyvitamin D3, Producing 1α,20,23-Trihydroxyvitamin D3, Which Has Altered Biological Activity , 2010, Drug Metabolism and Disposition.
[192] D. Prié,et al. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[193] M. Eriksson,et al. Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy , 2010, European journal of endocrinology.
[194] A. Vermeulen. The birth of endocrine pathology , 2010, Virchows Archiv.
[195] H. Glossmann. Origin of 7-dehydrocholesterol (provitamin D) in the skin. , 2010, The Journal of investigative dermatology.
[196] C. Mathieu,et al. Vitamin D: modulator of the immune system. , 2010, Current opinion in pharmacology.
[197] S. Shenolikar,et al. Role of NHERF and scaffolding proteins in proximal tubule transport , 2010, Urological Research.
[198] R. Wilkinson,et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. , 2010, The Journal of clinical endocrinology and metabolism.
[199] V. Lagishetty,et al. 1α-Hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[200] H. Leffers,et al. Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[201] A. Turner,et al. Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[202] Hilary F Luderer,et al. The vitamin D receptor, the skin and stem cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[203] Puneet Dhawan,et al. Vitamin D: metabolism. , 2010, Endocrinology and metabolism clinics of North America.
[204] M. Zeiger,et al. The Death of an Indian Rhinoceros , 2010, World Journal of Surgery.
[205] J. Forman,et al. Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans , 2010, Hypertension.
[206] William Wheeler,et al. Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.
[207] B. Menon,et al. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism—A longitudinal study , 2010, Seizure.
[208] Jia Hu,et al. Association between Vitamin D Receptor Gene Polymorphisms and Idiopathic Hypocitraturia in the Chinese Population , 2010, Urologia Internationalis.
[209] P. A. Friedman,et al. Parathyroid Hormone Receptor Directly Interacts with Dishevelled to Regulate β-Catenin Signaling and Osteoclastogenesis* , 2010, The Journal of Biological Chemistry.
[210] Hong-fu Wang,et al. Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts , 2010, Calcified Tissue International.
[211] A. Kalueff,et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[212] H. Wulf,et al. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. , 2010, The Journal of investigative dermatology.
[213] H. Jüppner,et al. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. , 2010, Annual review of medicine.
[214] A. Slominski,et al. 20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytes , 2009, Journal of cellular physiology.
[215] M. Levi,et al. PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI. , 2009, American journal of physiology. Cell physiology.
[216] R. Lefkowitz,et al. A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation , 2009, Science Translational Medicine.
[217] M. J. Mahon. The parathyroid hormone 1 receptor directly binds to the FERM domain of ezrin, an interaction that supports apical receptor localization and signaling in LLC-PK1 cells. , 2009, Molecular endocrinology.
[218] J. Walters,et al. Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[219] J. Reichrath,et al. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. , 2009, Anticancer research.
[220] J. Norris,et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. , 2009, The Journal of clinical endocrinology and metabolism.
[221] Bin Wang,et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. , 2009, Nature chemical biology.
[222] J. Hoenderop,et al. The role of transient receptor potential channels in kidney disease , 2009, Nature Reviews Nephrology.
[223] M. Lohse,et al. Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors , 2009, PLoS biology.
[224] K. Miyamoto,et al. The roles of Na/Pi-II transporters in phosphate metabolism. , 2009, Bone.
[225] A. Norman,et al. The Vitamin D Sterol–Vitamin D Receptor Ensemble Model Offers Unique Insights into Both Genomic and Rapid-Response Signaling , 2009, Science Signaling.
[226] M. Mohammadi,et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. , 2009, American journal of physiology. Renal physiology.
[227] K. Miyamoto,et al. Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency , 2009, American journal of physiology. Renal physiology.
[228] D. Rao,et al. Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[229] J. Silver,et al. The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells , 2009, BMC Biology.
[230] A. Avenell,et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. , 2009, The Cochrane database of systematic reviews.
[231] F. Schaefer,et al. Differential Regulation of RGS-2 by Constant and Oscillating PTH Concentrations , 2009, Calcified Tissue International.
[232] Guilin Qiao,et al. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. , 2008, Kidney international.
[233] U. Jeon. Kidney and Calcium Homeostasis , 2008, Electrolyte & blood pressure : E & BP.
[234] J. Weisel,et al. Endocrine functions of bone in mineral metabolism regulation. , 2008, The Journal of clinical investigation.
[235] B. Gérard,et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. , 2008, The New England journal of medicine.
[236] A. Bajwa,et al. Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells. , 2008, Archives of biochemistry and biophysics.
[237] J. Norris,et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.
[238] F. Castellino,et al. A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis. , 2008, Journal of the American Society of Nephrology : JASN.
[239] D. Shoback. Clinical practice. Hypoparathyroidism. , 2008, The New England journal of medicine.
[240] B. Hollis,et al. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. , 2008, Endocrinology.
[241] R. St-Arnaud. The direct role of vitamin D on bone homeostasis. , 2008, Archives of biochemistry and biophysics.
[242] S. Shenolikar,et al. Urine electrolyte, mineral, and protein excretion in NHERF-2 and NHERF-1 null mice. , 2008, American journal of physiology. Renal physiology.
[243] Aamir Ahmad,et al. Novel regulatory function for NHERF-1 in Npt2a transcription. , 2008, American journal of physiology. Renal physiology.
[244] K. Sakaguchi,et al. Predominant role of 25OHD in the negative regulation of PTH expression: clinical relevance for hypovitaminosis D. , 2008, Life sciences.
[245] M. Haussler,et al. Vitamin D Receptor: Key Roles in Bone Mineral Pathophysiology, Molecular Mechanism of Action, and Novel Nutritional Ligands , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[246] T. Gardella,et al. Progress, Paradox, and Potential , 2007, Annals of the New York Academy of Sciences.
[247] D. Sitara. Correlation among Hyperphosphatemia, Type II Sodium–Phosphate Transporter Activity, and Vitamin D Metabolism in Fgf‐23 Null Mice , 2007, Annals of the New York Academy of Sciences.
[248] S. Shenolikar,et al. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1. , 2007, The Journal of clinical investigation.
[249] Wei Zheng,et al. 1,25-Dihydroxyvitamin D3 Suppresses Renin Gene Transcription by Blocking the Activity of the Cyclic AMP Response Element in the Renin Gene Promoter* , 2007, Journal of Biological Chemistry.
[250] F. Gejyo,et al. Role of Megalin, a Proximal Tubular Endocytic Receptor, in Calcium and Phosphate Homeostasis , 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[251] G. Åkerström,et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. , 2007, The Journal of endocrinology.
[252] K. Miyamoto,et al. New Aspect of Renal Phosphate Reabsorption: The Type IIc Sodium-Dependent Phosphate Transporter , 2007, American Journal of Nephrology.
[253] R. D. Nerenz,et al. Characterizing Early Events Associated with the Activation of Target Genes by 1,25-Dihydroxyvitamin D3 in Mouse Kidney and Intestine in Vivo* , 2007, Journal of Biological Chemistry.
[254] Xavier Deupi,et al. Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.
[255] K. Skorija,et al. Vitamin D receptor is essential for normal keratinocyte stem cell function , 2007, Proceedings of the National Academy of Sciences.
[256] H. DeLuca,et al. Nuclear receptor 4A2 and C/EBPβ regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1α-hydroxylase , 2007 .
[257] C. Carlberg,et al. Selective use of multiple vitamin D response elements underlies the 1 α,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene , 2007, Nucleic acids research.
[258] Sungtae Kim,et al. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[259] B. Lanske,et al. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[260] Sungtae Kim,et al. 1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[261] M. Haussler,et al. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[262] M. Wjst,et al. A genome-wide linkage scan for 25-OH-D3 and 1,25-(OH)2-D3 serum levels in asthma families , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[263] Y. Helfrich,et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.
[264] R. Simpson,et al. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[265] Mi-Sun Kim,et al. RETRACTED: Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[266] J. Adams,et al. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[267] T. Craig,et al. Biological activity of FGF-23 fragments , 2007, Pflügers Archiv - European Journal of Physiology.
[268] S. Shenolikar,et al. Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice. , 2007, American journal of physiology. Cell physiology.
[269] Jeffrey E. Lee,et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. , 2007, The Journal of investigative dermatology.
[270] A. Plotnikov,et al. Structural analysis of CYP2R1 in complex with vitamin D3. , 2007, Journal of molecular biology.
[271] E. Meese,et al. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and –Resistant melanoma cells , 2007, Cancer biology & therapy.
[272] P. Carmeliet,et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. , 2006, The Journal of clinical investigation.
[273] A. Negri. Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D‐binding protein/25‐(OH)D3 complex (Review Article) , 2006, Nephrology.
[274] H. Höfler,et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans , 2006, Proceedings of the National Academy of Sciences.
[275] E. Nemeth,et al. The parathyroid polyhormone hypothesis revisited. , 2006, Kidney international. Supplement.
[276] Sungtae Kim,et al. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. , 2006, Molecular endocrinology.
[277] R. Lefkowitz,et al. Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation* , 2006, Journal of Biological Chemistry.
[278] S. Shenolikar,et al. Longitudinal study of urinary excretion of phosphate, calcium, and uric acid in mutant NHERF-1 null mice. , 2006, American journal of physiology. Renal physiology.
[279] T. Strom,et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. , 2006, American journal of human genetics.
[280] F. Pattou,et al. 1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor , 2006, Apoptosis.
[281] M. Bastepe,et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. , 2006, American journal of human genetics.
[282] M. Ermani,et al. Biochemical markers of endothelial activation in primary hyperparathyroidism. , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[283] C. Wagner,et al. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. , 2006, Kidney international.
[284] J. Potts. Parathyroid hormone: past and present. , 2005, The Journal of endocrinology.
[285] M. Haussler,et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[286] S. Kato,et al. Retraction: ‘Ligand‐induced transrepression by VDR through association of WSTF with acetylated histones’ , 2005, The EMBO journal.
[287] H. Nagasawa,et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. , 2005, Anticancer research.
[288] M. Lohse,et al. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[289] John H. White,et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. , 2005, Molecular endocrinology.
[290] S. Shenolikar,et al. Defective PTH regulation of sodium-dependent phosphate transport in NHERF-1-/- renal proximal tubule cells and wild-type cells adapted to low-phosphate media. , 2005, American journal of physiology. Renal physiology.
[291] T. Yamashita. Structural and Biochemical Properties of Fibroblast Growth Factor 23 , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[292] A. Ferrante,et al. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site. , 2005, The Biochemical journal.
[293] N. Déliot,et al. NaPi‐IIa and interacting partners , 2005, The Journal of physiology.
[294] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[295] N. Déliot,et al. Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+/H+ exchanger regulatory factor-1 complexes. , 2005, American journal of physiology. Cell physiology.
[296] S. Maclean,et al. Backbone-methylated Analogues of the Principle Receptor Binding Region of Human Parathyroid Hormone , 2005, Journal of Biological Chemistry.
[297] K. White,et al. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. , 2005, Bone.
[298] H. Törmä,et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. , 2005, The Journal of investigative dermatology.
[299] N. Stern,et al. 25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.
[300] D. Rodeberg,et al. Primary Hyperparathyroidism in Pediatric Patients , 2005, Pediatrics.
[301] C. Mathieu,et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. , 2005, Endocrinology.
[302] G. Åkerström,et al. Parathyroid Glands in Calcium Regulation and Human Disease , 2005, Annals of the New York Academy of Sciences.
[303] P. A. Friedman,et al. Parathyroid Hormone Receptor Trafficking Contributes to the Activation of Extracellular Signal-regulated Kinases but Is Not Required for Regulation of cAMP Signaling* , 2005, Journal of Biological Chemistry.
[304] P. Mäenpää,et al. Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y. , 2005, Biochemical and biophysical research communications.
[305] Brendan C. Stack,et al. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[306] F. Schaefer,et al. Structural organization and biological relevance of oscillatory parathyroid hormone secretion , 2005, Pediatric Nephrology.
[307] N. Koszewski,et al. Contrasting mammalian PTH promoters: identification of transcription factors controlling PTH gene expression. , 2005, Clinical nephrology.
[308] J. Molkentin,et al. The protein phosphatase calcineurin determines basal parathyroid hormone gene expression. , 2005, Molecular endocrinology.
[309] L. Rao,et al. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. , 2005, Endocrine reviews.
[310] M. J. Mahon,et al. Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub‐set of class b G‐protein coupled receptors , 2005, FEBS letters.
[311] T. Gardella,et al. Novel Parathyroid Hormone (PTH) Antagonists That Bind to the Juxtamembrane Portion of the PTH/PTH-related Protein Receptor* , 2005, Journal of Biological Chemistry.
[312] T. Carling,et al. Parathyroid surgery in familial hyperparathyroid disorders * , 2005, Journal of internal medicine.
[313] J. Silver,et al. Identification and Characterization of cis‐Acting Elements in the Human and Bovine PTH mRNA 3′‐Untranslated Region , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[314] M. Razzaque,et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[315] D. Miao,et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. , 2004, Endocrinology.
[316] C. Wagner,et al. Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter. , 2004, Kidney international. Supplement.
[317] A. McDonough,et al. Acute hypotension induced by aortic clamp vs. PTH provokes distinct proximal tubule Na+ transporter redistribution patterns. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[318] G. Capasso,et al. An Overview of Divalent Cation and Citrate Handling by the Kidney , 2004, Nephron Physiology.
[319] M. Inoue,et al. Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi) , 2004, Pflügers Archiv.
[320] S. Shenolikar,et al. Defective Parathyroid Hormone Regulation of NHE3 Activity and Phosphate Adaptation in Cultured NHERF-1-/- Renal Proximal Tubule Cells* , 2004, Journal of Biological Chemistry.
[321] J. Hoenderop,et al. Effects of vitamin D compounds on renal and intestinal Ca2+ transport proteins in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice. , 2004, Kidney international.
[322] John H. White,et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.
[323] L. Adorini,et al. A Vitamin D Analog Down-Regulates Proinflammatory Chemokine Production by Pancreatic Islets Inhibiting T Cell Recruitment and Type 1 Diabetes Development1 , 2004, The Journal of Immunology.
[324] A. McDonough,et al. Differential traffic of proximal tubule Na+ transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes. , 2004, American journal of physiology. Renal physiology.
[325] J. Bertolini,et al. Therapeutic potential of vitamin D-binding protein. , 2004, Trends in biotechnology.
[326] E. Meese,et al. Analysis of the vitamin D system in basal cell carcinomas (BCCs) , 2004, Laboratory Investigation.
[327] P. A. Friedman,et al. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments. , 2004, Endocrinology.
[328] N. Koszewski,et al. Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer. , 2004, Endocrinology.
[329] G. Wolf. The discovery of vitamin D: the contribution of Adolf Windaus. , 2004, The Journal of nutrition.
[330] G. Segre,et al. Stimulation by Parathyroid Hormone of a NHERF-1-assembled Complex Consisting of the Parathyroid Hormone I Receptor, Phospholipase Cβ, and Actin Increases Intracellular Calcium in Opossum Kidney Cells* , 2004, Journal of Biological Chemistry.
[331] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[332] Guilin Qiao,et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[333] L. Nguyen,et al. Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[334] S. Kato,et al. RETRACTED: Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[335] P. Elias,et al. Mice lacking 25OHD 1α-hydroxylase demonstrate decreased epidermal differentiation and barrier function , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[336] D. Miao,et al. Inactivation of the 25-Hydroxyvitamin D 1α-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis* , 2004, Journal of Biological Chemistry.
[337] B. Harding,et al. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. , 2004, The Journal of clinical endocrinology and metabolism.
[338] P. Elias,et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. , 2004, The Journal of investigative dermatology.
[339] B. Teh,et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications , 2004, Journal of Medical Genetics.
[340] A. Weidema,et al. Characterization of a murine renal distal convoluted tubule cell line for the study of transcellular calcium transport. , 2004, American journal of physiology. Renal physiology.
[341] J. Reichrath,et al. Analysis of the vitamin D system in cutaneous squamous cell carcinomas , 2004, Journal of cutaneous pathology.
[342] F. Holstege,et al. Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice. , 2004, Kidney international.
[343] E. Ritz,et al. Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. , 2003, Journal of the American Society of Nephrology : JASN.
[344] E. Schipani,et al. PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. , 2003, Birth defects research. Part C, Embryo today : reviews.
[345] W. Miller,et al. Lack of mutations in CYP2D6 and CYP27 in patients with apparent deficiency of vitamin D 25-hydroxylase. , 2003, Molecular genetics and metabolism.
[346] J. Hoenderop,et al. Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney. , 2003, Journal of the American Society of Nephrology : JASN.
[347] S. Silverberg,et al. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. , 2003, The Journal of clinical endocrinology and metabolism.
[348] P. A. Friedman,et al. Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERF1 (EBP50)* , 2003, Journal of Biological Chemistry.
[349] J. Carpten,et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.
[350] Liaoyuan A. Hu,et al. Dishevelled 2 Recruits ß-Arrestin 2 to Mediate Wnt5A-Stimulated Endocytosis of Frizzled 4 , 2003, Science.
[351] S. Shenolikar,et al. Localization and interaction of NHERF isoforms in the renal proximal tubule of the mouse. , 2003, American journal of physiology. Cell physiology.
[352] S. Khundmiri,et al. Role of NHERF-1 in regulation of the activity of Na-K ATPase and sodium-phosphate co-transport in epithelial cells. , 2003, Journal of the American Society of Nephrology : JASN.
[353] N. Koszewski,et al. Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter. , 2003, Endocrinology.
[354] Hiromichi Nagasawa,et al. RETRACTED: The Chromatin-Remodeling Complex WINAC Targets a Nuclear Receptor to Promoters and Is Impaired in Williams Syndrome , 2003, Cell.
[355] M. Lohse,et al. Measurement of the millisecond activation switch of G protein–coupled receptors in living cells , 2003, Nature Biotechnology.
[356] J. Eisman,et al. Targeted Overexpression of Vitamin D Receptor in Osteoblasts Increases Calcium Concentration Without Affecting Structural Properties of Bone Mineral Crystals , 2003, Calcified Tissue International.
[357] J. Carpten,et al. Hyperparathyroidism‐jaw tumour syndrome , 2003, Journal of internal medicine.
[358] Wanjin Tang,et al. Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1. , 2003, The Biochemical journal.
[359] M. Rane,et al. Parathyroid Hormone Regulation of Type II Sodium-Phosphate Cotransporters Is Dependent on an A Kinase Anchoring Protein* , 2003, The Journal of Biological Chemistry.
[360] E. Wolf,et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[361] D. Rendina,et al. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis , 2003, Journal of internal medicine.
[362] H. DeLuca,et al. Regulation of 25‐hydroxyvitamin D3‐24‐hydroxylase mRNA by 1,25‐dihydroxyvitamin D3 and parathyroid hormone , 2003, Journal of cellular biochemistry.
[363] T. Lehnert,et al. PTH pulsatility but not calcium sensitivity is restored after total parathyroidectomy with heterotopic autotransplantation. , 2003, Journal of the American Society of Nephrology : JASN.
[364] H. Armbrecht,et al. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. , 2003, Archives of biochemistry and biophysics.
[365] J. Carpten,et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.
[366] L. Monticelli,et al. Selective Ligand-induced Stabilization of Active and Desensitized Parathyroid Hormone Type 1 Receptor Conformations* , 2002, The Journal of Biological Chemistry.
[367] M. Lohse,et al. Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. , 2002, Endocrinology.
[368] E. Nemeth. Pharmacological regulation of parathyroid hormone secretion. , 2002, Current pharmaceutical design.
[369] J. Hoenderop,et al. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25‐dihydroxyvitamin D3 in 25hydroxyvitamin D3‐1α‐hydroxylase knockout mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[370] C. Der,et al. Role of MAP Kinases in the 1,25-Dihydroxyvitamin D3-induced Transactivation of the Rat Cytochrome P450C24 (CYP24) Promoter , 2002, The Journal of Biological Chemistry.
[371] S. Shenolikar,et al. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[372] H. Morris,et al. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites. , 2002, The international journal of biochemistry & cell biology.
[373] M. Donowitz,et al. Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling , 2002, Nature.
[374] T. Saruta,et al. Identification of a renal proximal tubular cell-specific enhancer in the mouse 25-hydroxyvitamin d 1alpha-hydroxylase gene. , 2002, Journal of the American Society of Nephrology : JASN.
[375] M. Lohse,et al. Internalization Determinants of the Parathyroid Hormone Receptor Differentially Regulate β-Arrestin/Receptor Association* , 2002, The Journal of Biological Chemistry.
[376] H. DeLuca,et al. Vitamin D Receptor , 2002 .
[377] K. Martin,et al. Vitamin D analogues for the management of secondary hyperparathyroidism. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[378] M. Lohse,et al. Differential Conformational Requirements for Activation of G Proteins and the Regulatory Proteins Arrestin and G Protein-coupled Receptor Kinase in the G Protein-coupled Receptor for Parathyroid Hormone (PTH)/PTH-related Protein* , 2001, The Journal of Biological Chemistry.
[379] A. Abou-Samra,et al. Parathyroid hormone receptor internalization is independent of protein kinase A and phospholipase C activation. , 2001, American journal of physiology. Endocrinology and metabolism.
[380] H. Jüppner,et al. Multiple Sites of Contact between the Carboxyl-terminal Binding Domain of PTHrP-(1–36) Analogs and the Amino-terminal Extracellular Domain of the PTH/PTHrP Receptor Identified by Photoaffinity Cross-linking* , 2001, Journal of Biological Chemistry.
[381] R. Paschke,et al. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant? , 2001, European journal of endocrinology.
[382] S. Christakos,et al. Expression of Calbindin-D28k in a Pancreatic Isletβ -Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis. , 2001, Endocrinology.
[383] M. Tremblay,et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[384] S. Takeda,et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[385] L. Nguyen-Yamamoto,et al. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. , 2001, Endocrinology.
[386] T. Usdin,et al. Evaluating the Signal Transduction Mechanism of the Parathyroid Hormone 1 Receptor , 2001, The Journal of Biological Chemistry.
[387] S. Shenolikar,et al. NHERF: targeting and trafficking membrane proteins. , 2001, American journal of physiology. Renal physiology.
[388] I. Schuster,et al. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases , 2001, Steroids.
[389] A. Abou-Samra,et al. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction. , 2001, Biochemistry.
[390] F. R. Bringhurst,et al. Receptors for the Carboxyl-Terminal Region of PTH(1-84) Are Highly Expressed in Osteocytic Cells* *This work was supported by the NIH Grant DK-11794. , 2001, Endocrinology.
[391] K. Wikvall. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). , 2001, International journal of molecular medicine.
[392] M. Seibel,et al. Circannual Rhythms and Interactions of Vitamin D Metabolites, Parathyroid Hormone, and Biochemical Markers of Skeletal Homeostasis: A Prospective Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[393] S. Maclean,et al. Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: implications for receptor-activating conformations of the hormones. , 2000, Biochemistry.
[394] T. Meitinger,et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.
[395] L. Mulligan,et al. Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis , 2000, Journal of medical genetics.
[396] F. Ni,et al. Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone. , 2000, Biochemistry.
[397] P. Stern,et al. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. , 2000, Biochimica et biophysica acta.
[398] Sudhaker Rao,et al. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis , 2000, Clinical endocrinology.
[399] N. Chirgadze,et al. Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution. , 2000, The Journal of biological chemistry.
[400] T. Usdin,et al. Evaluating the Ligand Specificity of Zebrafish Parathyroid Hormone (PTH) Receptors: Comparison of PTH, PTH-Related Protein, and Tuberoinfundibular Peptide of 39 Residues. , 2000, Endocrinology.
[401] G. Hendy,et al. Dissection of differentially regulated (G+C)-rich promoters of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. , 2000, Endocrinology.
[402] M. Chorev,et al. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. , 2000, Biochemistry.
[403] A. Piserchio,et al. Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop. , 2000, Biochemistry.
[404] A. Abou-Samra,et al. Role of asparagine-linked oligosaccharides in the function of the rat PTH/PTHrP receptor. , 2000, Biochemistry.
[405] H. Völkl,et al. Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-P(i) cotransporter. , 2000, American journal of physiology. Renal physiology.
[406] A. Arnold,et al. Cyclin D1 in parathyroid disease. , 2000, Frontiers in bioscience : a journal and virtual library.
[407] G. Hendy,et al. Methylation patterns of human parathyroid hormone (PTH)/PTH-related peptide receptor gene promoters are established several weeks prior to onset of their function. , 2000, Biochemical and biophysical research communications.
[408] T. Schermerhorn,et al. Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. , 1999, The Journal of biological chemistry.
[409] S. Kato. Genetic mutation in the human 25-hydroxyvitamin D3 1α-hydroxylase gene causes vitamin D-dependent rickets type I , 1999, Molecular and Cellular Endocrinology.
[410] S. Shenolikar,et al. Molecular cloning of the cDNA and promoter sequences for the mouse sodium-hydrogen exchanger regulatory factor. , 1999, Biochimica et biophysica acta.
[411] J. Voorhees,et al. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. , 1999, Molecular endocrinology.
[412] H. Vorum,et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. , 1999, The American journal of pathology.
[413] J. Berg,et al. Vitamin D-binding protein prevents vitamin D deficiency and presents vitamin D for its renal activation. , 1999, European journal of endocrinology.
[414] L. Zon,et al. A G Protein-coupled Receptor from Zebrafish Is Activated by Human Parathyroid Hormone and Not by Human or Teleost Parathyroid Hormone-related Peptide , 1999, The Journal of Biological Chemistry.
[415] G. Hendy,et al. Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans. , 1999, The Journal of clinical endocrinology and metabolism.
[416] J. Walters,et al. Factors involved in the duodenal expression of the human calbindin-D9k gene. , 1999, The Biochemical journal.
[417] B. Lanske,et al. Identification of a retinoic acid-inducible element in the murine PTH/PTHrP (parathyroid hormone/parathyroid hormone-related peptide) receptor gene. , 1999, Molecular endocrinology.
[418] M. Holick,et al. Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[419] H. DeLuca,et al. Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene. , 1999, Archives of biochemistry and biophysics.
[420] G. Wallukat,et al. Megalin Antagonizes Activation of the Parathyroid Hormone Receptor* , 1999, The Journal of Biological Chemistry.
[421] Henrik Vorum,et al. An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.
[422] S. Liebhaber,et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. , 1999, The Journal of clinical investigation.
[423] L. Suva,et al. Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone. , 1998, Molecular endocrinology.
[424] John H. White,et al. Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters. , 1998, The Journal of clinical investigation.
[425] L. Suva,et al. Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies* , 1998, The Journal of Biological Chemistry.
[426] S. Kato,et al. The Promoter of the Human 25-Hydroxyvitamin D31α-Hydroxylase Gene Confers Positive and Negative Responsiveness to PTH, Calcitonin, and 1α,25(OH)2D3☆☆☆ , 1998 .
[427] G. Muscat,et al. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. , 1998, Journal of molecular endocrinology.
[428] S. Shenolikar,et al. Structure-function of recombinant Na/H exchanger regulatory factor (NHE-RF). , 1998, The Journal of clinical investigation.
[429] N. Amizuka,et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[430] M. Chorev,et al. Addressing the Tertiary Structure of Human Parathyroid Hormone-(1–34)* , 1998, The Journal of Biological Chemistry.
[431] T. Drüeke,et al. Regulation of the transcription of parathyroid-hormone/parathyroid-hormone-related peptide receptor mRNA by dexamethasone in ROS 17/2.8 osteosarcoma cells. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[432] J. Silver,et al. RNA-Protein Binding and Post-transcriptional Regulation of Parathyroid Hormone Gene Expression by Calcium and Phosphate* , 1998, The Journal of Biological Chemistry.
[433] H. DeLuca,et al. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[434] S. Shenolikar,et al. The Na-H exchanger regulatory factor. , 1997, Experimental nephrology.
[435] W. V. D. Van de Ven,et al. Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Genomics.
[436] S. Maclean,et al. Cyclization by a Specific Lactam Increases the Ability of Human Parathyroid Hormone (hPTH)‐(1–31)NH2 to Stimulate Bone Growth in Ovariectomized Rats , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[437] C. Larsson,et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.
[438] M. Brandi,et al. Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1. , 1997, The Journal of clinical endocrinology and metabolism.
[439] N. Horiuchi,et al. Mouse Vitamin D-24-Hydroxylase: Molecular Cloning, Tissue Distribution, and Transcriptional Regulation by 1α,25-Dihydroxyvitamin D3. , 1997, Endocrinology.
[440] S. Eto,et al. Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor. , 1997, Endocrinology.
[441] L. Suva,et al. Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[442] B. Lanske,et al. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: a new PTH/PTHrP receptor splice variant that lacks the signal peptide. , 1997, Endocrinology.
[443] R. Vasavada,et al. Transfection and overexpression of the calcium binding protein calbindin-D28k results in a stimulatory effect on insulin synthesis in a rat beta cell line (RIN 1046-38). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[444] L. Suva,et al. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor. , 1996, Biochemistry.
[445] S. Goldring,et al. Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin , 1996, The Journal of Biological Chemistry.
[446] H. Jüppner,et al. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors. , 1996, Endocrinology.
[447] T. Usdin,et al. Converting Parathyroid Hormone-related Peptide (PTHrP) into a Potent PTH-2 Receptor Agonist* , 1996, The Journal of Biological Chemistry.
[448] T. Clemens,et al. Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. , 1996, Endocrinology.
[449] H. Hsiung,et al. Structure and functional expression of a complementary DNA for porcine parathyroid hormone/parathyroid hormone-related peptide receptor. , 1996, Biochimica et biophysica acta.
[450] T. Usdin,et al. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor. , 1996, Endocrinology.
[451] E. Nemeth,et al. The parathyroid calcium receptor: a novel therapeutic target for treating hyperparathyroidism , 1996, Pediatric Nephrology.
[452] J. O'riordan,et al. Translational regulation of parathyroid hormone gene expression and RNA: Protein interactions , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[453] G. Eknoyan. A history of the parathyroid glands. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[454] M. Pellegrini,et al. Conformation of parathyroid hormone antagonists by CD, nmr, and molecular dynamics simulations , 1995, Biopolymers.
[455] G. Segre,et al. Expression of parathyroid hormone receptors in MDCK and LLC-PK1 cells , 1995, Pflügers Archiv.
[456] C. Dotti,et al. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. , 1995, American journal of hypertension.
[457] K. Schlüter,et al. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. , 1995, The Biochemical journal.
[458] M. Thomasset,et al. Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3-receptor heterodimers with high affinity , 1995, Molecular and Cellular Endocrinology.
[459] J. Orloff,et al. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. , 1995, Endocrinology.
[460] J. C. Clarke,et al. Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters. , 1995, Nucleic acids research.
[461] M. Holick,et al. McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century. , 1994, The American journal of clinical nutrition.
[462] H. Jüppner,et al. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding. , 1994, Endocrinology.
[463] H. Jüppner,et al. Determinants of [Arg2]PTH-(1-34) binding and signaling in the transmembrane region of the parathyroid hormone receptor. , 1994, Endocrinology.
[464] K. O̸lgaard,et al. Metabolism of intact PTH by isolated perfused kidney and liver from uremic rats. , 1994, Experimental nephrology.
[465] J. C. Clarke,et al. Molecular cloning of the gene encoding the mouse parathyroid hormone/parathyroid hormone-related peptide receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[466] B. Lanske,et al. The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. , 1994, Biochemical and biophysical research communications.
[467] J. Wylie,et al. Carboxyl‐terminal parathyroid hormone peptide (53–84) elevates alkaline phosphatase and osteocalcin mRNA levels in SaOS‐2 cells , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[468] B. Stieger,et al. Apical and basolateral parathyroid hormone receptors in rat renal cortical membranes. , 1994, Endocrinology.
[469] W. Gronwald,et al. The structure of human parathyroid hormone from a study of fragments in solution using 1H NMR spectroscopy and its biological implications. , 1994, Biochemistry.
[470] H. Jüppner,et al. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). , 1994, Endocrinology.
[471] S. Goldring,et al. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family , 1993, Trends in Endocrinology & Metabolism.
[472] H. Jüppner,et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. , 1993, Endocrinology.
[473] B. Heitmann,et al. Effects of age, sex, season and diet on serum ionized calcium, parathyroid hormone and vitamin D in a random population , 1993, Journal of internal medicine.
[474] B. Kemp,et al. NMR solution structure of human parathyroid hormone(1-34). , 1993, Biochemistry.
[475] Kronis Ka,et al. Structure of human parathyroid hormone(1-34) in the presence of solvents and micelles , 1993 .
[476] B. Ponder,et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.
[477] T. Gardella,et al. Analysis of parathyroid hormone's principal receptor-binding region by site-directed mutagenesis and analog design. , 1993, Endocrinology.
[478] C. Healey,et al. Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2. , 1993, Human molecular genetics.
[479] E. Ogata,et al. Conserved mechanism of negative gene regulation by extracellular calcium. Parathyroid hormone gene versus atrial natriuretic polypeptide gene. , 1992, The Journal of clinical investigation.
[480] R. Somorjai,et al. Structural elements of human parathyroid hormone and their possible relation to biological activities. , 1992, Biochemistry.
[481] S. Nagataki,et al. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders. , 1992, Endocrinologia japonica.
[482] M. Sikorska,et al. Parathyroid hormone stimulates protein kinase C but not adenylate cyclase in mouse epidermal keratinocytes , 1992, Journal of cellular physiology.
[483] H. Murer,et al. Apical and basolateral effects of PTH in OK cells: Transport inhibition, messenger production, effects of pertussis toxin, and interaction with a PTH analog , 1991, The Journal of Membrane Biology.
[484] M. Freeman,et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. , 1991, Science.
[485] K. Tsai,et al. Age-related changes in vitamin D metabolites, osteocalcin, alkaline phosphatase and parathyrin in normal Chinese women in Taipei. , 1991, Journal of the Formosan Medical Association = Taiwan yi zhi.
[486] D Schomburg,et al. Investigation of the solution structure of the human parathyroid hormone fragment (1-34) by 1H NMR spectroscopy, distance geometry, and molecular dynamics calculations. , 1991, Biochemistry.
[487] H. Kronenberg,et al. Mutational analysis of the receptor-activating region of human parathyroid hormone. , 1991, The Journal of biological chemistry.
[488] H. Rasmussen,et al. Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. , 1991, Endocrinology.
[489] E. Keshet,et al. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. , 1990, The Journal of clinical investigation.
[490] K. Wright,et al. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[491] J. Silver,et al. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. , 1990, The Journal of clinical investigation.
[492] M. Montrose,et al. Parathyroid hormone regulation of Na+/H+ exchange in opossum kidney cells: polarity and mechanisms , 1990, Pflügers Archiv.
[493] K. O̸lgaard,et al. Metabolism of parathyroid hormone in isolated perfused rat kidney and liver combined. , 1990, Kidney international.
[494] L. Duong,et al. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. , 1990, Endocrinology.
[495] M. Holick,et al. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. , 1990, The American journal of clinical nutrition.
[496] S. Massry,et al. Effect of parathyroid hormone on human T cell activation. , 1990, Kidney international.
[497] M. Chorev,et al. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists. , 1990, Biochemistry.
[498] U. Pagotto,et al. Aldosterone and Pressor Responses to Angiotensin II in Primary Hyperparathyroidism , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[499] R. Nutt,et al. Renal and adrenal adenosine 3',5'-monophosphate production and corticosteroid secretion in response to synthetic chicken parathyroid hormone-(1-34). , 1989, Endocrinology.
[500] Y. Nakamura,et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. , 1989, The New England journal of medicine.
[501] G. Segre,et al. Peripheral metabolism of [35S]parathyroid hormone in vivo: influence of alterations in calcium availability and parathyroid status. , 1989, The Journal of endocrinology.
[502] R. Eddy,et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. , 1989, The Journal of clinical investigation.
[503] R. Morris,et al. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. , 1989, The Journal of clinical investigation.
[504] Reddy Gs,et al. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through the C-24 oxidation pathway , 1989 .
[505] D. Bikle,et al. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. , 1989, Endocrinology.
[506] M. Kleerekoper,et al. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. , 1988, The Journal of clinical endocrinology and metabolism.
[507] M. Thorpy,et al. Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations. , 1988, The Journal of clinical endocrinology and metabolism.
[508] H. Kronenberg,et al. Inhibition of parathyroid hormone bioactivity by human parathyroid hormone (PTH)-(3-84) and PTH-(8-84) synthesized in Escherichia coli. , 1988, Endocrinology.
[509] H. DeLuca. The vitamin D story: a collaborative effort of basic science and clinical medicine 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[510] R. Morris,et al. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. , 1987, The Journal of clinical investigation.
[511] H. Armbrecht,et al. Effect of age on renal responsiveness to parathyroid hormone and calcitonin in rats. , 1987, The Journal of endocrinology.
[512] A. Korkor. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. , 1987, The New England journal of medicine.
[513] L. Melton,et al. Effect of aging on vitamin D stores and bone density in women , 1987, Calcified Tissue International.
[514] M. Pines,et al. Response of adrenal cells to parathyroid hormone stimulation. , 1987, The Journal of endocrinology.
[515] B. Specker,et al. Calcium-regulating hormones and minerals from birth to 18 months of age: a cross-sectional study. II. Effects of sex, race, age, season, and diet on serum minerals, parathyroid hormone, and calcitonin. , 1986, Pediatrics.
[516] T. Shigematsu,et al. Human parathyroid hormone inhibits renal 24-hydroxylase activity of 25-hydroxyvitamin D3 by a mechanism involving adenosine 3',5'-monophosphate in rats. , 1986, Endocrinology.
[517] R. Turner,et al. Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis , 1985, Calcified Tissue International.
[518] P. Siiteri,et al. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. , 1985, The Journal of clinical endocrinology and metabolism.
[519] J. Adams,et al. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. , 1985, The Journal of clinical endocrinology and metabolism.
[520] D. Cardinali,et al. Changes in parathyroid hormone and calcium levels after superior cervical ganglionectomy of rats. , 1985, Neuroendocrinology.
[521] J. Habener,et al. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. , 1984, Physiological reviews.
[522] R. Kumar,et al. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. , 1984, The Journal of clinical investigation.
[523] R. Morris,et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. , 1984, The Journal of clinical investigation.
[524] J. Adams,et al. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. , 1983, The Journal of clinical investigation.
[525] J. Puschett,et al. Inhibition of renal brush border phosphate transport and stimulation of renal gluconeogenesis by cyclic amp and parathyroid hormone. , 1983, Biochemical pharmacology.
[526] A. Norman,et al. Regulation of vitamin D metabolism in normal human pregnancy. , 1983, The Journal of clinical endocrinology and metabolism.
[527] G. Segre,et al. Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. , 1982, Biochemistry.
[528] Justin M. Nolan,et al. Measurement of circulating vitamin D in man. , 1982, Clinica chimica acta; international journal of clinical chemistry.
[529] J. Parrish,et al. Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. , 1982, The New England journal of medicine.
[530] J. Adams,et al. INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.
[531] R. Lasker,et al. The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen Kindreds , 1981, Medicine.
[532] J. Adams,et al. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. , 1981, The New England journal of medicine.
[533] M. Holick,et al. Chemical synthesis of [1β-3H]1α,25-dihydroxyvitamin D3 and [1α-3H]1β,25-dihydroxyvitamin D3: Biological activity of 1β,25-dihydroxyvitamin D3 , 1980 .
[534] H. Armbrecht,et al. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat. , 1980, The Journal of clinical investigation.
[535] R. Anderson,et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. , 1980, Science.
[536] L. Klein. Direct measurement of bone resorption and calcium conservation during vitamin D deficiency or hypervitaminosis D. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[537] S. Klahr,et al. The peripheral metabolism of parathyroid hormone. , 1979, The New England journal of medicine.
[538] F. Glorieux,et al. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration. , 1979, Clinical science.
[539] M. Haussler,et al. Dynamic changes in circulating 1,25-dihydroxyvitamin D during reproduction in rats. , 1979, Science.
[540] L. Cavalli-Sforza,et al. Vitamin-D-binding protein in the Williams syndrome and idiopathic hypercalcemia. , 1978, The New England journal of medicine.
[541] L. Cavalli-Sforza,et al. Detection of genetic variation with radioactive ligands. I. Electrophoretic screening of plasma proteins with a selected panel of compounds. , 1977, American journal of human genetics.
[542] K. Hruska,et al. The renal handling of parathyroid hormone. Role of peritubular uptake and glomerular filtration. , 1977, The Journal of clinical investigation.
[543] B. Boucher,et al. VITAMIN-D METABOLISM IN NEPHROTIC SYNDROME , 1977, The Lancet.
[544] S. Klahr,et al. Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate CA++ concentrations. , 1977, The Journal of clinical investigation.
[545] E. Brown,et al. Family studies in patients with primary parathyroid hyperplasia. , 1977, The American journal of medicine.
[546] L. Avioli,et al. 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. , 1977, Science.
[547] J. Winnacker,et al. Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. , 1977, American journal of diseases of children.
[548] A. Mourant,et al. Sunshine and the geographical distribution of the alleles of the Gc system of plasma proteins , 1976, Human Genetics.
[549] H. DeLuca,et al. Control of renal vitamin D hydroxylases in birds by sex hormones. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[550] D. Goodman,et al. The transport of vitamin D and its 25-hydroxy metabolite in human plasma. Isolation and partial characterization of vitamin D and 25-hydroxyvitamin D binding protein. , 1976, The Journal of clinical investigation.
[551] H. DeLuca,et al. The effect of hepatectomy on the synthesis of 25-hydroxyvitamin D3. , 1976, The Journal of clinical investigation.
[552] J. Habener,et al. Metabolism of amino- and carboxyl-sequence immunoreactive parathyroid hormone in the bovine: evidence for peripheral cleavage of hormone. , 1976, Metabolism: clinical and experimental.
[553] J. Habener,et al. RAdioimmunoassay of human proparathyroid hormone: analysis of hormone content in tissue extracts and in plasma. , 1976, The Journal of clinical endocrinology and metabolism.
[554] A. Rich,et al. Pre-proparathyroid hormone: analysis of radioactive tryptic peptides and amino acid sequence. , 1976, Biochemistry.
[555] A. Rich,et al. Pre-proparathyroid hormone: fidelity of the translation of parathyroid messenger RNA by extracts of wheat germ. , 1976, Biochemistry.
[556] D. Goltzman,et al. Metabolism and biological activity of proparathyroid hormone and synthetic analogues in renal cortical membranes. , 1975, Endocrinology.
[557] U. Binswanger,et al. Regulation of circulating parathyroid hormone levels: Normal physiology and consequences in disorders of mineral metabolism , 1975, Klinische Wochenschrift.
[558] L. Cavalli-Sforza,et al. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[559] F. Morel,et al. Effects of parathyroidectomy and cyclic AMP on renal transport of phosphate, calcium, and magnesium. , 1974, The American journal of physiology.
[560] U. Binswanger,et al. Acute parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity. , 1974, Endocrinology.
[561] H. DeLuca,et al. Role of vitamin D metabolites in phosphate transport of rat intestine. , 1974, The Journal of nutrition.
[562] H. DeLuca,et al. The regulation of calciferol-25-hydroxylase in the chick. , 1974, Biochemical and biophysical research communications.
[563] J. Habener,et al. Parathyroid Secretion: Discovery of a Major Calcium-Dependent Protein , 1974, Science.
[564] A. H. Reed,et al. Estimation of norms from a controlled sample survey. II. Influence of body habitus, oral contraceptives, and other factors on values for the normal range derived from the SMA 12-60 screening group of tests. , 1973, Clinical chemistry.
[565] G. Levey,et al. Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. , 1973, The Journal of clinical investigation.
[566] J. Canterbury,et al. Multiple Immunoreactive Molecular Forms of Parathyroid Hormone in Human Serum 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[567] C. Arnaud,et al. Calcium-regulated parathyroid hormone peptidase. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[568] A. Tashjian,et al. Studies on the role of the liver in the metabolism of parathyroid hormone. I. Effects of partial hepatectomy and incubation of the hormone with tissue homogenates. , 1972, Endocrinology.
[569] H. DeLuca,et al. The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. , 1972, Endocrinology.
[570] A. Rich,et al. Proparathyroid hormone: identification of a biosynthetic precursor to parathyroid hormone. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[571] H. DeLuca,et al. Vitamin D Metabolism: The Role of Kidney Tissue , 1971, Science.
[572] S. Berson,et al. Clinical applications of radioimmunoassay of plasma parathyroid hormone. , 1971, The American journal of medicine.
[573] H. DeLuca,et al. The role of the liver in the metabolism of vitamin D. , 1969, The Journal of clinical investigation.
[574] D. Fraser,et al. Conformational Similarities of Vitamin D and Cholesterol as Enzyme Substrates , 1968, Nature.
[575] H. DeLuca,et al. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. , 1968, Biochemistry.
[576] S. Berson,et al. Immunochemical heterogeneity of parathyroid hormone in plasma. , 1968, The Journal of clinical endocrinology and metabolism.
[577] S. Berson,et al. Radioimmunoassays of peptide hormones in plasma. , 1967, The New England journal of medicine.
[578] H. Rasmussen,et al. PURIFICATION OF PARATHYROID HORMONE BY USE OF COUNTERCURRENT DISTRIBUTION , 1959 .
[579] P. Handler,et al. Effect of parathyroid extract on renal excretion of phosphate. , 1951, The American journal of physiology.
[580] F. Albright,et al. A page out of the history of hyperparathyroidism. , 1948, The Journal of clinical endocrinology and metabolism.
[581] J. B. Collip,et al. The effect of parathyroid hormone upon the serum calcium and calcium excretion of normal and adrenalectomized rats. , 1936, The Biochemical journal.
[582] W. Bauer,et al. STUDIES IN PARATHYROID PHYSIOLOGY: III. The Effect of Phosphate Ingestion in Clinical Hyperparathyroidism. , 1932, The Journal of clinical investigation.
[583] M. Holick,et al. Vitamin D , 1928, Dermato-endocrinology.
[584] L. Dragstedt. THE PHYSIOLOGY OF THE PARATHYROID GLANDS , 1927 .
[585] Collip Jb. Clinical Use of the Parathyroid Hormone , 1925 .
[586] J. B. Collip. The Internal Secretion of the Parathyroid Glands. , 1925, Proceedings of the National Academy of Sciences of the United States of America.
[587] R. A. Lambert,et al. THE REMOVAL OF CALCIUM FROM THE BLOOD BY DIALYSIS IN THE STUDY OF TETANY , 1914, The Journal of experimental medicine.
[588] W. G. Maccallum,et al. FURTHER EXPERIMENTAL STUDIES IN TETANY , 1913, The Journal of experimental medicine.
[589] C. Voegtlin,et al. ON THE RELATION OF TETANY TO THE PARATHYROID GLANDS AND TO CALCIUM METABOLISM , 1909, The Journal of experimental medicine.
[590] R. Cohen,et al. Role of regulator of G protein signaling proteins in bone. , 2014, Frontiers in bioscience.
[591] M. Cantorna,et al. Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase. , 2014, The Journal of nutritional biochemistry.
[592] S. Gandini,et al. Vitamin D receptor polymorphisms and cancer. , 2014, Advances in experimental medicine and biology.
[593] S. Hauptlorenz,et al. 25-hydroxy-Vitamin D status: limitations in comparison and clinical interpretation of serum-levels across different assay methods. , 2014, Clinical laboratory.
[594] W. Kuebler,et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. , 2014, Molecular endocrinology.
[595] T. Reunala,et al. Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation. , 2014, Acta dermato-venereologica.
[596] W. März,et al. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. , 2014, Metabolism: clinical and experimental.
[597] Hilary F Luderer,et al. Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury. , 2013, Endocrinology.
[598] S. Silverberg,et al. Normocalcemic primary hyperparathyroidism. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[599] M. Brandi,et al. Hereditary hyperparathyroidism syndromes. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[600] R. Lefkowitz. Arrestins come of age: a personal historical perspective. , 2013, Progress in molecular biology and translational science.
[601] K. Miyamoto,et al. Vitamin D and type II sodium-dependent phosphate cotransporters. , 2013, Contributions to nephrology.
[602] P. Munroe,et al. Vitamin D and high blood pressure: causal association or epiphenomenon? , 2013, European Journal of Epidemiology.
[603] S. Silverberg,et al. Asymptomatic primary hyperparathyroidism. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[604] J. Potts. A short history of parathyroid hormone, its biological role, and pathophysiology of hormone excess. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[605] J. Bilezikian,et al. Bone turnover markers in primary hyperparathyroidism. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[606] N. Pellegata,et al. Multiple endocrine neoplasia type 4. , 2013, Frontiers of hormone research.
[607] L. Quarles,et al. Regulation and function of the FGF23/klotho endocrine pathways. , 2012, Physiological reviews.
[608] I. Christakis,et al. The history of the parathyroid glands , 2011, Hormones.
[609] S. Kato,et al. Williams syndrome is an epigenome-regulator disease. , 2011, Endocrine journal.
[610] P. A. Friedman,et al. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm , 2010, Cellular and Molecular Life Sciences.
[611] S. Kato,et al. Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+-dependent phosphate cotransporters , 2010, Pflügers Archiv - European Journal of Physiology.
[612] D. Bikle. Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.
[613] M. Matsumoto,et al. Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. , 2009, Journal of the American Society of Nephrology : JASN.
[614] M. Nesbit,et al. Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[615] M. Vidal,et al. Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling. , 2007, Developmental cell.
[616] M. J. Mahon,et al. A docking site for G protein βγ subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. , 2006, Molecular endocrinology.
[617] J. Säve‐Söderbergh,et al. A case of lethal congenital dwarfism with accelerated skeletal maturation , 2006, Pediatric Radiology.
[618] S. Epstein,et al. Lack of influence of isoproterenol, propranolol, and dopamine on immunoreactive parathyroid hormone and calcitonin in normal man , 2006, Calcified Tissue International.
[619] L. Mulligan. From Genes to Decisions , 2005 .
[620] M. Holick,et al. Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[621] M. Chorev. Parathyroid hormone 1 receptor: insights into structure and function. , 2002, Receptors & channels.
[622] A. Abou-Samra,et al. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. , 2002, Molecular endocrinology.
[623] F. R. Bringhurst,et al. Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor. , 2002, Endocrinology.
[624] H. Morris,et al. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. , 2002, Annual review of nutrition.
[625] L. P. Van den Heuvel,et al. Autosomal recessive hypophosphataemic rickets with hypercalciuria is not caused by mutations in the type II renal sodium/phosphate cotransporter gene. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[626] F. Schaefer. Pulsatile parathyroid hormone secretion in health and disease. , 2000, Novartis Foundation symposium.
[627] S. Yamamoto,et al. Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats. , 1998, Endocrinology.
[628] G. Hendy,et al. Cell-Specific Expression of the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Kidney from Kidney-Specific and Ubiquitous Promoters1. , 1997, Endocrinology.
[629] D Schomburg,et al. Structure of recombinant human parathyroid hormone in solution using multidimensional NMR spectroscopy. , 1996, Biological chemistry Hoppe-Seyler.
[630] D. Clayton,et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.
[631] D. Cardinali,et al. Influence of the autonomic nervous system on calcium homeostasis in the rat. , 1994, Biological signals.
[632] H. Jüppner,et al. Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells. , 1994, Endocrinology.
[633] K. O̸lgaard,et al. Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. , 1994, Mineral and electrolyte metabolism.
[634] H. Murer,et al. Parathyroid hormone receptors in control of proximal tubule function. , 1992, Annual review of physiology.
[635] E. Molto,et al. Possible case of hyperparathyroidism in a Roman period skeleton from the Dakhleh Oasis, Egypt, diagnosed using bone histomorphometry. , 1988, American journal of physical anthropology.
[636] R. Morris,et al. Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. , 1986, The Journal of clinical investigation.
[637] M. Freeman,et al. Structure and expression of the human parathyroid hormone gene. , 1986, Recent progress in hormone research.
[638] E. Mellerup,et al. Seasonal variation in urinary excretion of calcium, magnesium and phosphate in manic-melancholic patients. , 1984, Chronobiology international.
[639] S. Daiger,et al. Heritability of quantitative variation at the group-specific component (Gc) locus. , 1984, American journal of human genetics.
[640] M. A. Levine,et al. Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. , 1982, The New England journal of medicine.
[641] J. Blum,et al. Parathyroid hormone response to hypocalcaemia following hypercalcaemia. , 1981, Acta endocrinologica.
[642] J. Habener,et al. Subcellular distributions of parathyroid hormone, hormonal precursors, and parathyroid secretory protein. , 1979, Endocrinology.
[643] J. Habener,et al. Relative effectiveness of magnesium and calcium on the secretion and biosynthesis of parathyroid hormone in vitro. , 1976, Endocrinology.
[644] D. Goltzman,et al. Metabolism and biological activity of parathyroid hormone in renal cortical membranes. , 1976, The Journal of clinical investigation.
[645] H. DeLuca,et al. Subcellular location of rat liver calciferol-25-hydroxylase. , 1974, Archives of biochemistry and biophysics.
[646] O. Ohara,et al. The FASEB Journal FJ Express Full-Length Article , 2022 .